HIGHLIGHTS
- who: Zijun Yan et al. from the School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Yunnan, Kunming, China have published the Article: Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis, in the Journal: Journal of Immunology Research of 20/04/2022
- what: The authors exploited the experiments to explore the effect of NCTD-NLC on liver cancer cells: the HepG2 cells cultured in vitro were given with NCTD-NLC administration; then the estimation on cellular proliferation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.